Biggest changeDue to the nature of long-term agreements in the Engineering Technologies segment, the timing of orders and delivery dates can vary considerably resulting in significant backlog changes from one period to another. 23 Table of Contents Backlog orders are as follows (in thousands): As of June 30, 2024 As of June 30, 2023 Total Backlog under Total Backlog under Backlog 1 year Backlog 1 year Electronics $ 107,006 $ 94,982 $ 150,061 $ 129,911 Engraving 22,483 20,874 36,817 31,434 Scientific 2,646 2,646 2,506 2,506 Engineering Technologies 64,592 50,122 63,769 52,565 Specialty Solutions 16,691 16,672 21,749 21,634 Total $ 213,418 $ 185,296 $ 274,902 $ 238,050 Total backlog realizable within one year decreased $52.8 million, or 22.2% to $185.2 million at June 30, 2024 from $238.1 million at June 30, 2023.
Biggest changeBacklog orders are as follows (in thousands): As of June 30, 2025 As of June 30, 2024 Total Backlog under Total Backlog under Backlog 1 year Backlog 1 year Electronics $ 144,971 $ 121,276 $ 107,006 $ 94,982 Engineering Technologies 91,025 82,273 64,592 50,122 Scientific 3,974 3,974 2,646 2,646 Engraving 22,460 22,123 22,483 20,874 Specialty Solutions 16,045 15,950 16,691 16,672 Total $ 278,475 $ 245,596 $ 213,418 $ 185,296 Total backlog realizable within one year increased $60.3 million, or 32.5% to $245.6 million at June 30, 2025 from $185.2 million at June 30, 2024.
Organic sales decreased by $37.7 million, or 5.1%, due to transitory headwinds in several of our end markets, primarily due to lower demand in our Electronics, Specialty and Scientific segments, partially offset by project timing in our Engineering Technologies group. Organic sales included $94.0 million in the period attributed to fast growth markets.
Organic sales decreased by $37.7 million, or 5.1%, due to transitory headwinds in several of our end markets, primarily due to lower demand in our Electronics, Scientific and Specialty segments, partially offset by project timing in our Engineering Technologies group. Organic sales included $94.0 million in the period attributed to fast growth markets.
Gross Profit Gross profit in fiscal year 2024 decreased to $282.0 million, or a gross margin of 39.1%, as compared to $285.1 million, or a gross margin of 38.5%, for the prior year period.
Gross profit in fiscal year 2024 decreased to $282.0 million, or a gross margin of 39.1%, as compared to $285.1 million, or a gross margin of 38.5%, for the prior year period.
Income from Operations Income from operations for the fiscal year 2024 was $101.7 million, compared to $171.1 million during the prior year.
Income from operations for the fiscal year 2024 was $101.7 million, compared to $171.1 million during the prior year.
The Company’s annual test for impairment is performed using a May 31st measurement date. We have identified six reporting units for impairment testing: Electronics, Engraving, Scientific, Engineering Technologies, Federal, and Hydraulics. As quoted market prices are not available for the Company’s reporting units, the fair value of the reporting units is determined using a discounted cash flow model (income approach).
The Company’s annual test for impairment is performed using a May 31st measurement date. We have identified six reporting units for impairment testing: Electronics, Engineering Technologies, Scientific, Engraving, Federal, and Hydraulics. As quoted market prices are not available for the Company’s reporting units, the fair value of the reporting units is determined using a discounted cash flow model (income approach).
The income tax provision from continuing operations for the fiscal year ended June 30, 2024 was impacted by the following items: (i) a tax provision of $3.1 million due to the mix of income in various jurisdictions, (ii) tax benefits of $2.8 million related to foreign tax credits of $0.7 million, as well as Federal R&D tax credits of $2.1 million, (iii) a tax provision of $3.8 million related to officers’ compensation, and (iv) a tax benefit of $3.9 million relating to share-based compensation.
The income tax provision from continuing operations for the fiscal year ended June 30, 2024 was impacted by the following items: (i) a tax provision of $3.1 million due to the mix of income in various jurisdictions, (ii) tax benefits of $2.8 million related to foreign tax credits of $0.7 million, as well as Federal R&D tax credits of $2.1 million, (iii) a tax provision of $3.8 million related to officers’ compensation, and (iv) a tax benefit of $3.8 million relating to share-based compensation.
Under the terms of the Credit Facility, we will pay a variable rate of interest and a fee on borrowed amounts as well as a commitment fee on unused amounts under the facility.
Under the terms of the Credit Facility, we pay a variable rate of interest and a fee on borrowed amounts as well as a commitment fee on unused amounts under the facility.
A twenty-five-basis point change in our discount rate, holding all other assumptions constant, would have no impact on 2024 pension expense as changes to amortization of net losses would be offset by changes to interest cost. In future years, the impact of discount rate changes could yield different sensitivities.
A twenty-five-basis point change in our discount rate, holding all other assumptions constant, would have no impact on 2025 pension expense as changes to amortization of net losses would be offset by changes to interest cost. In future years, the impact of discount rate changes could yield different sensitivities.
We have evaluated the current and long-term cash requirements of our defined benefit and defined contribution plans as of June 30, 2024 and determined our operating cash flows from continuing operations and available liquidity are expected to be sufficient to cover the required contributions under ERISA and other governing regulations.
We have evaluated the current and long-term cash requirements of our defined benefit and defined contribution plans as of June 30, 2025 and determined our operating cash flows from continuing operations and available liquidity are expected to be sufficient to cover the required contributions under ERISA and other governing regulations.
The most significant assumption involved in the Company’s determination of fair value is the cash flow projections of each reporting unit. As a result of our annual assessment in the fourth quarter of fiscal year 2024, the Company determined that the fair value of the six reporting units substantially exceeded their respective carrying values.
The most significant assumption involved in the Company’s determination of fair value is the cash flow projections of each reporting unit. As a result of our annual assessment in the fourth quarter of fiscal year 2025, the Company determined that the fair value of the six reporting units substantially exceeded their respective carrying values.
In the past year, we have experienced price fluctuations for a number of materials including rhodium, steel, and other metal commodities. These materials are some of the key elements in the products manufactured in these segments. Wherever possible, we will implement price increases to offset the impact of changing prices.
We have experienced price fluctuations for a number of materials including rhodium, steel, and other metal commodities. These materials are some of the key elements in the products manufactured in these segments. Wherever possible, we will implement price increases to offset the impact of changing prices.
Therefore, no impairment charges were recorded in connection with our annual assessment during the fourth quarter of fiscal year 2024. Cost of Employee Benefit Plans – We provide a range of benefits to certain retirees, including pensions and some postretirement benefits.
Therefore, no impairment charges were recorded in connection with our annual assessment during the fourth quarter of fiscal year 2025. Cost of Employee Benefit Plans – We provide a range of benefits to certain retirees, including pensions and some postretirement benefits.
The ultimate acceptance of these price increases, if implemented, will be impacted by our affected divisions’ respective competitors and the timing of their price increases. In general, we do not enter into purchase contracts that extend beyond one operating cycle.
The ultimate acceptance of these price increases will be impacted by our affected divisions’ respective competitors and the timing of their price increases. In general, we do not enter into purchase contracts that extend beyond one operating cycle.
The expected return on plan assets assumption of 6.4% in the U.S. is based on our expectation of the long-term average rate of return on assets in the pension funds and is reflective of the current and projected asset mix of the funds and considers the historical returns earned on the funds.
The expected return on plan assets assumption of 6.35% in the U.S. is based on our expectation of the long-term average rate of return on assets in the pension funds and is reflective of the current and projected asset mix of the funds and considers the historical returns earned on the funds.
Based on information provided by our actuaries and other relevant sources, we believe that our assumptions are reasonable. 31 Table of Contents The cost of employee benefit plans includes the selection of assumptions noted above.
Based on information provided by our actuaries and other relevant sources, we believe that our assumptions are reasonable. 25 Table of Contents The cost of employee benefit plans includes the selection of assumptions noted above.
Summary of Accounting Policies” for information regarding the effect of recently issued accounting pronouncements on our consolidated statements of operations, comprehensive income, stockholders’ equity, cash flows, and notes for the year ended June 30, 2024.
Summary of Accounting Policies” for information regarding the effect of recently issued accounting pronouncements on our consolidated statements of operations, comprehensive income, stockholders’ equity, cash flows, and notes for the year ended June 30, 2025 .
A description of any such material trends is described below in the applicable segment analysis. We monitor a number of key performance indicators (“KPIs”) including net sales, income from operations, backlog, effective income tax rate, gross profit margin, and operating cash flow. A discussion of these KPIs is included below.
A description of any such material trends is described below in the applicable segment analysis. 17 Table of Contents We monitor a number of key performance indicators (“KPIs”) including net sales, income from operations, backlog, effective income tax rate, gross profit margin, and operating cash flow. A discussion of these KPIs is included below.
The Company’s current financial covenants under the facility are as follows: 28 Table of Contents Interest Coverage Ratio - The Company is required to maintain a ratio of Earnings Before Interest and Taxes, as Adjusted (“Adjusted EBIT per the Credit Facility”), to interest expense for the trailing twelve months of at least 2.75:1.
The Company’s current financial covenants under the facility are as follows: Interest Coverage Ratio - The Company is required to maintain a ratio of Earnings Before Interest and Taxes, as Adjusted (“Adjusted EBIT per the Credit Facility”), to interest expense for the trailing twelve months of at least 2.75:1.
Our annual impairment testing at each reporting unit relied on assumptions surrounding general market conditions, short-term growth rates, a terminal growth rate of 2.5%, and detailed management forecasts of future cash flows prepared by the relevant reporting unit. Fair values were determined primarily by discounting estimated future cash flows at a weighted average cost of capital of 11.0%.
Our annual impairment testing at each reporting unit relied on assumptions surrounding general market conditions, short-term growth rates, a terminal growth rate of 2.5%, and detailed management forecasts of future cash flows prepared by the relevant reporting unit. Fair values were determined primarily by discounting estimated future cash flows at a weighted average cost of capital of 9.84%.
Net sales decreased reflecting general market softness, including purchases by retail pharmacies. 25 Table of Contents Income from operations in fiscal year 2024 increased by $1.9 million, or 11.1%, when compared to the prior year. Operating income increase reflects productivity initiatives and lower freight costs, partially offset by lower volume.
Net sales decreased reflecting general market softness, including purchases by retail pharmacies. Income from operations in fiscal year 2024 increased $1.9 million or 11.1%, when compared to the prior year. Operating income increase reflects productivity initiatives and lower freight costs, partially offset by lower volume.
The amount of the commitment fee will depend upon both the undrawn amount remaining available under the facility and the Company’s funded debt to EBITDA (as defined in the agreement) ratio at the last day of each quarter.
The amount of the commitment fee depends upon both the undrawn amount remaining available under the facility and the Company’s funded debt to EBITDA (as defined in the agreement) ratio at the last day of each quarter.
The Company’s pension plan is frozen for U.S. employees and participants in the plan ceased accruing future benefits. Our primary U.S. defined benefit plan is not 100% funded under ERISA rules at June 30, 2024. U.S. defined benefit plan contributions of $10.0 million were made during fiscal year 2024 compared to $0.2 million during fiscal year 2023.
The Company’s pension plan is frozen for U.S. employees and participants in the plan ceased accruing future benefits. Our primary U.S. defined benefit plan is not 100% funded under ERISA rules at June 30, 2025. U.S. defined benefit plan contributions of $7.6 million were made during fiscal year 2025 compared to $10.0 million during fiscal year 2024.
The gain on sale of business, restructuring costs, acquisition related costs and other operating income (expense), net have been discussed above in the Company Overview. Discontinued Operations In pursing our business strategy, the Company may divest certain businesses. Future divestitures may be classified as discontinued operations based on their strategic significance to the Company.
The gain on sale of business, restructuring costs, acquisition-related costs and other operating income (expense), net have been discussed above in the Company Overview. 22 Table of Contents Discontinued Operations In pursuing our business strategy, the Company may divest certain businesses. Future divestitures may be classified as discontinued operations based on their strategic significance to the Company.
Adjusted EBIT per the Credit Facility specifically excludes extraordinary and certain other defined items such as cash restructuring and acquisition related charges up to the lower of $20.0 million or 10% of EBITDA. The facility allows for unlimited non-cash charges including purchase accounting and goodwill adjustments. At June 30, 2024, the Company’s Interest Coverage Ratio was 25.15.:1.
Adjusted EBIT per the Credit Facility specifically excludes extraordinary and certain other defined items such as cash restructuring and acquisition related charges up to the lower of $20.0 million or 10% of EBITDA. The facility allows for unlimited non-cash charges including purchase accounting and goodwill adjustments. At June 30, 2025, the Company’s Interest Coverage Ratio was 6.42:1.
The fair value of the Company's U.S. defined benefit pension plan assets was $142.3 million at June 30, 2024, as compared to $142.1 million as of June 30, 2023. We participate in two multi-employer pension plans and sponsor six defined benefit plans including two in the U.S. and Japan and one each in the U.K. and Germany.
The fair value of the Company's U.S. defined benefit pension plan assets was $146.4 million at June 30, 2025, as compared to $142.3 million as of June 30, 2024. We participate in two multi-employer pension plans and sponsor six defined benefit plans including two in the U.S. and Japan and one each in the U.K. and Germany.
There are required contributions of $5.8 million to the United States funded pension plan for fiscal year 2025. The Company expects to make contributions during fiscal year 2025 of $0.2 million and $0.3 million to its unfunded defined benefit plans in the U.S. and Germany, respectively. Any subsequent plan contributions will depend on the results of future actuarial valuations.
There are required contributions of $6.5 million to the United States funded pension plan for fiscal year 2026. The Company expects to make contributions during fiscal year 2026 of $0.1 million and $0.3 million to its unfunded defined benefit plans in the U.S. and Germany, respectively. Any subsequent plan contributions will depend on the results of future actuarial valuations.
While Standex considers our relationship with our suppliers to be good, there can be no assurances that we will not experience any supply shortage. Foreign Currency Translation – Our primary functional currencies used by our non-U.S. subsidiaries are the Euro, British Pound Sterling (Pound), Japanese (Yen), Peso and Chinese (Yuan).
While Standex considers our relationship with our suppliers to be good, there can be no assurances that we will not experience any supply shortage. 24 Table of Contents Foreign Currency Translation – Our primary functional currencies used by our non-U.S. subsidiaries are the Euro, British Pound Sterling (Pound), Japanese (Yen), Mexican Peso, Chinese (Yuan), and Indian (Rupee).
Organic sales decreased by $1.0 million, or 0.7%, as a result of delays in new platform rollouts in North America. Foreign exchange impacts were $0.4 million, or 0.2%. Income from operations in fiscal year 2024 increased by $1.2 million, or 4.9%, when compared to the prior year.
Net sales in fiscal year 2024 decreased by $1.4 million or 0.9% compared to the prior year. Organic sales decreased by $1.0 million, or 0.7%, as a result of delays in new platform rollouts in North America. Foreign exchange impacts were $0.4 million, or 0.2%.
Under certain circumstances in connection with a Material Acquisition (as defined in the Facility), the Facility allows for the leverage ratio to go as high as 4.0:1 for a four-fiscal quarter period. At June 30, 2024, the Company’s Leverage Ratio was 0.65:1. As of June 30, 2024, we had borrowings under our facility of $150.0 million.
Under certain circumstances in connection with a Material Acquisition (as defined in the Facility), the Facility allows for the leverage ratio to go as high as 4.0:1 for a four-fiscal quarter period. At June 30, 2025, the Company’s Leverage Ratio was 2.60:1. As of June 30, 2025, we had borrowings under our facility of $553.2 million.
For discussion of the impact of acquisitions, we isolate the effect on the KPI amount that would have existed regardless of our acquisition. Sales resulting from synergies between the acquisition and existing operations of the Company are considered organic growth for the purposes of our discussion.
For discussion of the impact of acquisitions, we isolate the effect on the KPI amount that would have existed regardless of our acquisition. Sales resulting from synergies between the acquisition and existing operations of the Company are considered organic growth for the purposes of our discussion. Unless otherwise noted, references to years are to fiscal years.
At June 30, 2024, the underlying policies had a cash surrender value of $11.7 million and are reported net of loans of $4.9 million for which we have the legal right of offset. These amounts are reported net on our balance sheet.
At June 30, 2025, the underlying policies had a cash surrender value of $6.7 million and are reported net of loans of $2.7 million for which we have the legal right of offset. These amounts are reported net on our balance sheet.
Our primary cash requirements in addition to day-to-day operating needs include interest payments, capital expenditures, acquisitions, share repurchases, and dividends. Our primary sources of cash are cash flows from continuing operations and borrowings under the facility.
The effective rate of interest for our outstanding borrowings is 6.38%. Our primary cash requirements in addition to day-to-day operating needs include interest payments, capital expenditures, acquisitions, share repurchases, and dividends. Our primary sources of cash are cash flows from continuing operations and borrowings under the facility.
This transaction reflects the continued simplification of our portfolio and enables greater focus on managing our larger platforms and pursuing growth opportunities. Proceeds will be deployed towards organic and inorganic initiatives and returning capital to shareholders. Its results are reported within our Specialty Solutions segment.
This transaction reflected the continued simplification of our portfolio and enabled greater focus on managing our larger platforms and pursuing growth opportunities. Proceeds were deployed towards organic and inorganic initiatives and returning capital to shareholders. Its results were reported within our Specialty Solutions segment.
Additionally, most of the Company’s contracts offer assurance type warranties in connection with the sale of a product to customers. Assurance type warranties provide a customer with assurance that the product complies with agreed-upon specifications.
Additionally, most of the Company’s contracts offer assurance type warranties in connection with the sale of a product to customers. Assurance type warranties provide a customer with assurance that the product complies with agreed-upon specifications. Assurance type warranties do not represent a separate performance obligation.
At June 30, 2024, we expect to pay estimated post-retirement benefit payments of $6.0 million during fiscal year 2025. See "Item 8. Financial Statements and Supplementary Data, Note 16. Employee Benefit Plans" for additional information regarding these obligations. At June 30, 2024, we had $39.0 million of operating lease obligations. See "Item 8. Financial Statements and Supplementary Data, Note 20.
At June 30, 2025 , we expect to pay estimated post-retirement benefit payments of $6.9 million during fiscal year 2026. See "Item 8. Financial Statements and Supplementary Data, Note 16. Employee Benefit Plans" for additional information regarding these obligations. A t June 30, 2025 , we had $51.2 million of operating lease obligations. See "Item 8.
Acquisitions had a $1.9 million, or 0.3%, positive impact on sales, offset by negative impacts on sales for divestitures of $11.9 million, or 1.9%, and foreign currency of $23.9 million, or 3.3%. We discuss our results and outlook for each segment below.
Acquisitions had a $40.4 million, or 5.5%, positive impact on sales, offset by negative impacts on sales for divestitures of $21.3 million, or 2.9%, and foreign currency of $1.8 million, or 0.3%. We discuss our results and outlook for each segment below.
Our policy is to fund domestic pension liabilities in accordance with the minimum and maximum limits imposed by the Employee Retirement Income Security Act of 1974 ("ERISA"), federal income tax laws and the funding requirements of the Pension Protection Act of 2006.
Post-retirement benefits and pension plan contribution payments represent future pension payments to comply with local funding requirements. Our policy is to fund domestic pension liabilities in accordance with the minimum and maximum limits imposed by the Employee Retirement Income Security Act of 1974 ("ERISA"), federal income tax laws and the funding requirements of the Pension Protection Act of 2006.
Engineering Technologies 2024 compared to 2023 2023 compared to 2022 (in thousands except % % percentages) 2024 2023 Change 2023 2022 Change Net sales $83,476 $81,079 3.0% $81,079 $78,117 3.8% Income from operations 15,216 11,050 37.7% 11,050 8,776 25.9% Operating income margin 18.2% 13.6% 13.6% 11.2% Net sales in fiscal year 2024 increased $2.4 million, or 3.0%, when compared to the prior year.
Engineering Technologies 2025 compared to 2024 2024 compared to 2023 (in thousands except % % percentages) 2025 2024 Change 2024 2023 Change Net sales $102,595 $83,476 22.9% $83,476 $81,079 3.0% Income from operations 15,428 15,216 1.4% 15,216 11,050 37.7% Operating income margin 15.0% 18.2% 18.2% 13.6% Net sales in fiscal year 2025 increased $19.1 million, or 22.9%, when compared to the prior year.
In fiscal year 2023, we received $67.0 million cash consideration and recorded a pre-tax gain on the sale of $62.1 million in the Consolidated Financial Statements.
In fiscal year 2023, we received $67.0 million cash consideration and recorded a pre-tax gain on the sale of $62.1 million in the Consolidated Financial Statements. Cash consideration received at closing excludes amounts held in escrow and was net of closing cash.
Net cash provided by continuing operating activities for the year ended June 30, 2023 was $90.8 million compared to net cash provided by continuing operating activities of $78.1 million in the prior year. We generated $116.6 million from income statement activities and used $18.2 million of cash to fund working capital and other balance sheet account increases.
Net cash provided by continuing operating activities for the year ended June 30, 2024 was $93.3 million compared to net cash provided by continuing operating activities of $90.8 million in the prior year. We generated $111.4 million from income statement activities and used $5.1 million of cash to fund working capital and other balance sheet account increases.
Activity related to discontinued operations is as follows (in thousands): Year Ended June 30, 2024 2023 2022 (Loss) before taxes $ (654 ) $ (204 ) $ (113 ) Benefit for taxes 137 43 24 Net (loss) from discontinued operations $ (517 ) $ (161 ) $ (89 ) Liquidity and Capital Resources At June 30, 2024, our total cash balance was $154.2 million, of which $128.1 million was held outside of the United States.
Activity related to discontinued operations is as follows (in thousands): Year Ended June 30, 2025 2024 2023 (Loss) before taxes $ (53 ) $ (654 ) $ (204) Benefit for taxes 11 137 43 Net (loss) from discontinued operations $ (42 ) $ (517 ) $ (161) Liquidity and Capital Resources At June 30, 2025, our total cash balance was $104.5 million, of which $78.7 million was held outside of the United States.
Engraving 2024 compared to 2023 2023 compared to 2022 (in thousands except % % percentages) 2024 2023 Change 2023 2022 Change Net sales $150,685 $152,067 (0.9%) $152,067 $146,255 4.0% Income from operations 26,708 25,462 4.9% 25,462 21,825 16.7% Operating income margin 17.7% 16.7% 16.7% 14.9% Net sales in fiscal year 2024 decreased by $1.4 million, or 0.9%, compared to the prior year.
Engraving 2025 compared to 2024 2024 compared to 2023 (in thousands except % % percentages) 2025 2024 Change 2024 2023 Change Net sales $128,360 $150,685 (14.8%) $150,685 $152,067 (0.9%) Income from operations 17,647 26,708 (33.9%) 26,708 25,462 4.9% Operating income margin 13.7% 17.7% 17.7% 16.7% Net sales in fiscal year 2025 decreased by $ 22.3 million, or 14.8% , compared to the prior year.
Its results are reported within our Electronics segment. 19 Table of Contents As a result of these portfolio moves, we have transformed Standex to a company with a more focused group of businesses selling customized solutions to high value end markets via a compelling customer value proposition.
As a result of these portfolio moves, we have transformed Standex to a company with a more focused group of businesses selling customized solutions to high value end markets via a compelling customer value proposition.
Corporate, Restructuring and Other 2024 compared to 2023 2023 compared to 2022 (in thousands except % % percentages) 2024 2023 Change 2023 2022 Change Corporate $ (32,183) $ (35,207) (8.6%) $ (35,207) $ (34,413) 2.3% Gain (loss) on sale of business 274 62,105 (99.6%) 62,105 - 100.0% Restructuring costs (8,206) (3,831) 114.2% (3,831) (4,399) (12.9%) Acquisition related costs (2,622) (557) 370.7% (557) (1,618) (65.6%) Other operating income (expense), net (110) 611 (118.0%) 611 (5,745) (110.6%) Corporate expenses in fiscal year 2024 decreased $3.0 million, or 8.6%, when compared to the prior year.
Corporate, Restructuring and Other 2025 compared to 2024 2024 compared to 2023 (in thousands except % % percentages) 2025 2024 Change 2024 2023 Change Corporate - Income from operations $ (31,427) $ (32,183) (2.3%) $ (32,183) $ (35,207) (8.6%) Gain (loss) on sale of business - $ 274 (100.0%) 274 62,105 (99.6%) Restructuring costs (6,903) $ (8,206) (15.9%) (8,206) (3,831) 114.2% Acquisition related costs (21,434) $ (2,622) 717.5% (2,622) (557) 370.7% Other operating income (expense), net - $ (110) (100.0%) (110) 611 (118.0%) Corporate expenses in fiscal year 2025 decreased $0.8 million, or 2.3%, when compared to the prior year, primarily due to reduction in incentive compensation.
We used $48.8 million for the purchase of acquisitions in the fiscal year and $20.3 million was used for capital expenditures. We generated $7.8 million in the fiscal year of proceeds from the divestiture of the Procon business.
Cash flow used in investing activities for the year ended June 30, 2024 totaled $61.6 million. We used $48.8 million for the purchase of acquisitions in the fiscal year and $20.3 million was used for capital expenditures. We generated $7.8 million in the fiscal year of proceeds from the divestiture of the Procon business.
Interest expense for fiscal year 2023 was $5.4 million, a decrease of $0.5 million as compared to the prior year. 22 Table of Contents Income Taxes The income tax provision from continuing operations for the fiscal year ended June 30, 2024 was $21.5 million, or an effective rate of 22.6%, compared to $24.8 million, or an effective rate of 15.1%, for the year ended June 30, 2023, and $19.8 million, or an effective rate of 24.4%, for the year ended June 30, 2022.
Income Taxes The income tax provision from continuing operations for the fiscal year ended June 30, 2025 was $11.1 million, or an effective rate of 16.11%, compared to $21.5 million, or an effective rate of 22.6%, for the year ended June 30, 2024, and $24.8 million, or an effective rate of 15.1%, for the year ended June 30, 2023.
We generated $111.4 million from income statement activities and used $5.1 million of cash to fund working capital and other balance sheet account increases. Cash flow used in investing activities for the year ended June 30, 2024 totaled $61.6 million.
We generated $102.0 million from income statement activities and u sed $12.9 million of cash to fund working capital and other balance sheet account increases. Cash flow used in investing activities for the year ended June 30, 2025 totaled $ 503.4 million.
Gross profit was also negatively impacted by the divestiture of the Procon business. 21 Table of Contents Selling, General, and Administrative Expenses Selling, general, and administrative expenses, (“SG&A”) for the fiscal year 2024 were $169.6 million, or 23.5% of sales, compared to $172.3 million, or 23.3% of sales, during the prior year period.
Selling, general, and administrative expenses, (“SG&A”) for the fiscal year 2024 were $169.6 million, or 23.5% of sales, compared to $172.3 million, or 23.3% of sales, during the prior year period.
Unless otherwise noted, references to years are to fiscal years. 20 Table of Contents Consolidated Results from Continuing Operations (in thousands): 2024 2023 2022 Net sales $ 720,635 $ 741,048 $ 735,339 Gross profit margin 39.1 % 38.5 % 36.7 % Restructuring costs 8,206 3,831 4,399 Acquisition related expenses 2,622 557 1,618 Other operating (income) expense, net 110 (611 ) 5,745 (Gain) loss on sale of business (274 ) (62,105 ) - Income from operations 101,738 171,089 88,294 Backlog (realizable within 1 year) $ 185,296 $ 274,902 $ 256,248 2024 2023 2022 Net sales $ 720,635 $ 741,048 $ 735,339 Components of change in sales: Effect of acquisitions 40,427 1,919 1,918 Effect of exchange rates (1,842 ) (23,902 ) (9,874 ) Effect of business divestitures (21,259 ) (11,947 ) (9,239 ) Organic sales change (37,739 ) 39,639 96,302 Net sales decreased for fiscal year 2024 by $20.4 million, or 2.8%, when compared to the prior year period.
Consolidated Results from Continuing Operations (in thousands): 2025 2024 2023 Net sales $ 790,107 $ 720,635 $ 741,048 Gross profit margin 39.9 % 39.1 % 38.5% Restructuring costs 6,903 8,206 3,831 Acquisition related expenses 21,434 2,622 557 Other operating (income) expense, net - 110 (611) (Gain) loss on sale of business - (274 ) (62,105) Income from operations 93,549 101,738 171,089 Backlog (realizable within 1 year) $ 245,596 $ 185,296 $ 274,902 2025 2024 2023 Net sales $ 790,107 $ 720,635 $ 741,048 Components of change in sales: Effect of acquisitions 123,636 40,427 1,919 Effect of exchange rates (343 ) (1,842 ) (23,902) Effect of business divestitures - (21,259 ) (11,947) Organic sales change (53,821 ) (37,739 ) 39,639 Net sales increased for fiscal year 2025 by $69.5 million, or 9.6% when compared to the prior year period.
Inflation for medical costs can impact both our employee benefit costs as well as our reserves for workers' compensation claims. We monitor the inflationary rate and make adjustments to reserves whenever it is deemed necessary.
Inflation – Certain of our expenses, such as wages and benefits, occupancy costs, freight and equipment repair and replacement, are subject to normal inflationary pressures. Inflation for medical costs can impact both our employee benefit costs as well as our reserves for workers' compensation claims. We monitor the inflationary rate and make adjustments to reserves whenever it is deemed necessary.
We sponsor a number of defined benefit and defined contribution retirement plans. The U.S. pension plan is frozen for all participants. We have evaluated the current and long-term cash requirements of these plans, and our existing sources of liquidity are expected to be sufficient to cover required contributions under ERISA and other governing regulations.
We have evaluated the current and long-term cash requirements of these plans, and our existing sources of liquidity are expected to be sufficient to cover required contributions under ERISA and other governing regulations.
Cash used by financing activities for the year ended June 30, 2024 was $69.2 million and included stock repurchases of $31.8 million, repayments of debt of $25.0 million and cash paid for dividends of $13.9 million.
Cash used by financing activities for the year ended June 30, 2024 was $69.2 million and included stock repurchases of $31.8 million, repayments of debt of $25.0 million and cash paid for dividends of $13.9 million. We sponsor a number of defined benefit and defined contribution retirement plans. The U.S. pension plan is frozen for all participants.
We expect that fiscal year 2025 depreciation and amortization expense will be between $24.0 million and $28.0 million and $8.0 million and $10.0 million, respectively.
We expect that fiscal year 2026 depreciation and amortization expense will be between $24.0 million and $26.0 million and $15.5 million and $17.5 million, respectively.
SG&A expenses during the period were impacted by a reduction in general and administrative expenses partially offset by increased research and development spending. Selling, general, and administrative expenses, (“SG&A”) for the fiscal year 2023 were $172.3 million, or 23.3% of sales, compared to $169.9 million, or 23.1% of sales, during the prior year period.
Selling, General, and Administrative Expenses Selling, general, and administrative expenses, (“SG&A”) for the fiscal year 2025 were $193.4 million, or 24.5% of sales, compared to $169.9 million, or 23.5% of sales, during the prior year period. SG&A expenses during the period were primarily impacted by increased expenses due to the recent acquisitions and increased research and development and selling expenses.
Funds borrowed under the facility may be used for the repayment of debt, working capital, capital expenditures, acquisitions (so long as certain conditions, including a specified funded debt to EBITDA leverage ratio is maintained), and other general corporate purposes.
Funds borrowed under the facility may be used for the repayment of debt, working capital, capital expenditures, acquisitions (so long as certain conditions, including a specified funded debt to EBITDA leverage ratio is maintained), and other general corporate purposes. 23 Table of Contents During the second quarter of fiscal year 2025, we entered into a $250 million 364-day term loan with existing lenders.
The Company's net (cash) debt to capital percentage changed to (0.9)% as of June 30, 2024 from (3.8)% in the prior year. At June 30, 2024, we expect to pay estimated interest payments of $2.8 million within the next five years.
The Company's net (cash) debt to capital percentage changed to (38.6)% as of June 30, 2025 from (0.9)% in the prior year. At June 30, 2025, we expect to pay estimated interest payments of $176 million within the next five years. This estimate is based upon the loan balance, interest rate, and credit spread as of June 30, 2025.
SG&A expenses during the period were primarily impacted by increased research and development spending to drive future product initiatives. Restructuring Costs During fiscal year 2024, we incurred restructuring expenses of $8.2 million, primarily related to facility rationalization activities, and global headcount reductions primarily within our Engraving, Electronics and Engineering Technologies segments and as well as the Corporate headquarters.
During fiscal year 2024, we incurred restructuring expenses of $8.2 million, primarily related to facility rationalization activities, and global headcount reductions primarily within our Electronics, Engineering Technologies and Engraving segments and as well as the Corporate headquarters. Acquisition Related Costs We incurred acquisition related expenses of $21.4 million and $2.6 million in fiscal year 2025 and 2024, respectivel y.
Sensor Solutions was acquired in the third quarter of fiscal year 2022, adding $1.9 million, or 0.6%, in sales for the period. The foreign currency impact decreased sales by $14.0 million, or 4.6%. Income from operations in the fiscal year 2023 decreased $1.4 million, or 2.1% when compared to the prior year.
The foreign currency impact decreased sales by $1.6 million, or 0.5%. Income from operations in the fiscal year 2024 decreased $4.9 million, or 7.2% when compared to the prior year.
Specialty Solutions 2024 compared to 2023 2023 compared to 2022 (in thousands except % % percentages) 2024 2023 Change 2023 2022 Change Net sales $95,587 $127,106 (24.8%) $127,106 $122,827 3.5% Income from operations 19,631 25,368 (22.6%) 25,368 15,579 62.8% Operating income margin 20.5% 20.0% 20.0% 12.7% Net sales for fiscal year 2024 decreased $31.5 million, or 24.8% when compared to the prior year.
Specialty Solutions 2025 compared to 2024 2024 compared to 2023 (in thousands except % % percentages) 2025 2024 Change 2024 2023 Change Net sales $86,642 $95,587 (9.4%) $95,587 $127,106 (24.8%) Income from operations 14,841 19,631 (24.4%) 19,631 25,368 (22.6%) Operating income margin 17.1% 20.5% 20.5% 20.0% Net sales for fiscal year 2025 decreased $8.9 million, or 9.4% when compared to the prior year reflecting general market softness in the Display Merchandising business and in the Hydraulics business.
Discussion of the performance of each of our reportable segments is fully explained in the segment analysis that follows. Interest Expense Interest expense for fiscal year 2024 was $4.5 million, a decrease of $0.9 million as compared to the prior year. Our effective interest rate was 2.46%.
Our effective interest rate in fiscal 2025 was 6.38%. Interest expense for fiscal year 2024 was $4.5 million, a decrease of $0.9 million as compared to the prior year.
Assurance type warranties do not represent a separate performance obligation. 30 Table of Contents In general, the Company recognizes revenue at the point in time control transfers to their customer based on predetermined shipping terms.
In general, the Company recognizes revenue at the point in time control transfers to their customer based on predetermined shipping terms.
The income tax provision from continuing operations for the fiscal year ended June 30, 2022 was impacted by the following items: (i) a tax provision of $4.3 million due to the mix of income in various jurisdictions, (ii) a tax benefit of $2.2 million related to Federal R&D credit and Foreign Tax Credit, (iii) a tax benefit of $1.3 million related to return-to-accrual adjustments to true-up prior-period provision amounts, and (iv) a tax expense of $1.0 million related to uncertain tax position.
The income tax provision from continuing operations for the fiscal year ended June 30, 2025 was impacted by the following items: (i) a tax provision of $5.8 million due to the mix of income in various jurisdictions, (ii) tax benefits of $4.7 million related to foreign tax credits of $2.1 million, as well as Federal R&D tax credits of $2.5 million, (iii) a tax provision of $1.8 million related to officers’ compensation, (iv) a tax provision of $3.0 million related to cash repatriation, and (v) a tax benefit of $9.1 million (inclusive of $1.2 million of interest) related to the release of a Sec. 965 toll tax uncertain tax position due to the lapse of statute of limitations.
The repatriation of cash balances from certain of our subsidiaries could have adverse tax consequences or be subject to capital controls; however, those balances are generally available without legal restrictions to fund ordinary business operations. 27 Table of Contents Cash Flow Net cash provided by continuing operating activities for the year ended June 30, 2024 was $93.3 million compared to net cash provided by continuing operating activities of $90.8 million in the prior year.
The repatriation of cash balances from certain of our subsidiaries could have adverse tax consequences or be subject to capital controls; however, those balances are generally available without legal restrictions to fund ordinary business operations.
Other Operating (Income) Expense, Net We recorded a charge of $0.1 million for settlement of an environmental remediation claim in the third quarter of fiscal year 2024. We incurred expense of $5.7 million in fiscal year 2022 related to a litigation accrual.
Acquisition related costs typically consist of due diligence, integration, and valuation expenses incurred in connection with recent or pending acquisitions. Other Operating (Income) Expense, Net We recorded a charge of $0.1 million for settlement of an environmental remediation claim in the third quarter of fiscal year 2024.
Income from operations for fiscal year 2024 decreased $5.7 million, or 22.6%, when compared to the prior year.
Income from operations for fiscal year 2025 decreased $4.8 million, or 24.4%, when compared to the prior year due to lower volumes. Net sales for fiscal year 2024 decreased $31.5 million, or 24.8% when compared to the prior year.
Corporate expenses in fiscal year 2024 reflect reductions in professional service fees and incentive compensation. Corporate expenses in fiscal year 2023 increased $0.8 million, or 2.3%, when compared to the prior year, primarily due to employee related compensation accruals and research and development costs.
Corporate expenses in fiscal year 2024 decreased $3.0 million, or 8.6%, when compared to the prior year. Corporate expenses in fiscal year 2024 reflect reductions in incentive compensation.
The following table sets forth our capitalization at June 30: 2024 2023 Long-term debt $ 148,876 $ 173,441 Less cash and cash equivalents 154,203 195,706 Net (cash) debt (5,327 ) (22,265 ) Stockholders' equity 621,503 607,449 Total capitalization $ 616,176 $ 585,184 Stockholders’ equity increased year over year by $14.0 million, primarily as a result of current year net income of $73.1 million offset by $45.7 million of cash returned to shareholders in the form of dividends and stock repurchases.
The following table sets forth our capitalization at June 30: 2025 2024 Long-term debt $ 552,515 $ 148,876 Less cash and cash equivalents 104,542 154,203 Net (cash) debt 447,973 (5,327) Stockholders' equity 711,677 621,503 Total capitalization $ 1,159,650 $ 616,176 Stockholders’ equity increased year over year by $90.2 million, primarily as a result of current year net income of $55.7 million and stock issued for acquisitions of $26 million.
Scientific 2024 compared to 2023 2023 compared to 2022 (in thousands except % % percentages) 2024 2023 Change 2023 2022 Change Net sales $68,931 $74,924 (8.0%) $74,924 $83,850 (10.6%) Income from operations 19,000 17,109 11.1% 17,109 17,861 (4.2%) Operating income margin 27.6% 22.8% 22.8% 21.3% Net sales in fiscal year 2024 decreased by $6.0 million, or 8.0% when compared to the prior year.
Scientific 2025 compared to 2024 2024 compared to 2023 (in thousands except % % percentages) 2025 2024 Change 2024 2023 Change Net sales $72,380 $68,931 5.0% $68,931 $74,924 (8.0%) Income from operations 17,470 19,000 (8.1%) 19,000 17,109 11.1% Operating income margin 24.1% 27.6% 27.6% 22.8% Net sales in fiscal year 2025 increased by $ 3.4 million, or 5.0% when compared to the prior year, due to benefit from the Custom Biogenic Systems acquisition, mostly offset by an organic decline from lower demand at academic and research institutions that were impacted by NIH funding cuts.
As of June 30, 2024, the Company has used $2.7 million against the letter of credit sub-facility and had the ability to borrow $347.3 million under the facility based on our current trailing twelve-month EBITDA. The facility contains customary representations, warranties and restrictive covenants, as well as specific financial covenants.
This amendment expanded the total available credit under the Revolving Credit Agreement from $500 million to $825 million. As of June 30, 2025 , the Company has used $1.9 million against the letter of credit sub-facility and had the ability to borrow $207.7 million under the facility based on our current trailing twelve-month EBITDA.
During fiscal year 2024, capital expenditures were $20.3 million or 2.8% of net sales, as compared to $24.3 million, or 3.3%, of net sales in the prior year. We expect 2025 capital spending to be between $35 million and $40 million. Backlog Backlog includes all active or open orders for goods and services.
In general, we anticipate our capital expenditures over the long-term will be approximately 3% to 5% of net sales. During fiscal year 2025, capital expenditures were $28.8 million or 3.6% of net sales, as compared to $20.3 million, or 2.8%, of net sales in the prior year. We expect 2026 capital spending to be between $33 million and $38 million.
Backlog also includes any future deliveries based on executed customer contracts, so long as such deliveries are based on agreed upon delivery schedules. Backlog orders are not necessarily an indicator of future sales levels because of variations in lead times and customer production demand pull systems, with the exception of Engineering Technologies.
Backlog orders are not necessarily an indicator of future sales levels because of variations in lead times and customer production demand pull systems, with the exception of Engineering Technologies. Customers may delay delivery of products or cancel orders prior to shipment, subject to possible cancellation penalties.
Income from operations in the fiscal year 2024 decreased $4.9 million, or 7.2%, when compared to the prior year. The operating income decrease was the result of lower sales, a change in product mix and foreign currency impacts, partially offset by contributions from the recent acquisitions, and realization of pricing and productivity initiatives.
Income from operations in fiscal year 2025 decreased by $9.1 million, or 33.9%, when compared to the prior year primarily as a result of lower demand in North America, partially offset by productivity actions. Net sales in fiscal year 2024 decreased by $1.4 million or 0.9% compared to the prior year.
Operating income increased during the period reflecting productivity actions, offsetting slower demand in North America sales. In the first quarter of fiscal year 2025, we expect moderately higher revenue and operating margin due to more favorable project timing in Europe and Asia. Net sales in fiscal year 2023 increased by $5.8 million or 4.0% compared to the prior year.
Income from operations in fiscal year 2024 increased by $1.2 million, or 4.9%, when compared to the prior year. Operating income increased during the period reflecting productivity actions, offsetting slower demand in North America sales.
Business, above, for additional information regarding our segment structure and management strategy. As part of our ongoing strategy: o On May 3, 2024, we acquired Sanyu Electric Pte Ltd, or SEPL, a privately held distributor of reed relays.
Its results are reported in the Electronics segment beginning in the second quarter of fiscal year 2025. o On May 3, 2024, we acquired Sanyu Electric Pte Ltd, or SEPL, a privately held distributor of reed relays.
Leases" for additional information regarding these obligations. At June 30, 2024 , we had $ 9.8 million of non-current liabilities for uncertain tax positions.
Financial Statements and Supplementary Data, Note 20. Leases" for additional information regarding these obligations. At June 30, 2025 , w e had $2.9 million of non-current liabilities for uncertain tax positions. We are not able to pro vide a reasonable estimate of the timing of future payments related to these obligations.
The increase was primarily due to the impact of pricing and productivity initiatives, partially offset by research and development. In the first quarter of fiscal year 2025, on a sequential basis, we expect moderately to significantly lower revenue and slightly lower operating margin due to unfavorable project timing.
The increase was primarily due to the impact of pricing and productivity initiatives, partially offset by research and development.
Cash used by financing activities for the year ended June 30, 2023 was $40.0 million and included stock repurchases of $25.5 million, cash paid for dividends of $13.0 million, contingent consideration payments to the sellers of the Renco business of $1.2 million and debt modification costs of $1.7 million.
Cash provided by financing activities for the year ended June 30, 2025 was $380.5 million and included proceeds from borrowings of $792.3 million, payment of debt of $389 million, stock repurchases of $9.9 million and cash paid for dividends of $ 15.0 million.
The operating income decrease was the result of inflationary impacts, mix and foreign exchange offset partially by organic sales growth and various cost saving initiatives.
The operating income decrease was the result of $1.8 million purchase accounting adjustments on both Minntronix and Sanyu along with the operating margin impact on the lower organic sales, mix, among other cost variances offset partially by the acquisition operating margin and various cost saving initiatives.
The decrease is due to the Procon divestiture and lower volume in the Display Merchandising and Hydraulics business, partially offset by improved operating performance in the Display Merchandising business. 26 Table of Contents In the first quarter of fiscal year 2025, on a sequential basis, we expect similar revenue and operating margin.
Income from operations for fiscal year 2024 decreased $5.7 million, or 22.6%, when compared to the prior year. The decrease is due to the Procon divestiture and lower volume in the Display Merchandising and Hydraulics business, partially offset by improved operating performance in the Display Merchandising business.
Net sales in fiscal year 2023 increased $3.0 million, or 3.8%, when compared to the prior year. Organic sales increased by $4.1 million, or 5.3%, offset by foreign currency impacts of $1.1 million, or 1.5%, as compared to the prior year period.
Income from operations in fiscal year 2025 decreased by $ 1.5 million, or 8.1% , when compared to the prior year due to organic decline partially offset by contribution from the acquisition and price and productivity initiatives. 21 Table of Contents Net sales in fiscal year 2024 decreased by $6.0 million, or 8.0% when compared to the prior year.